SEC Form 4 · accession 0001209191-15-085625
Arcadia Biosciences, Inc. · RKDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven F. Brandwein
Officer — Interim Chief Financ. Officer
Period of report
Dec 15, 2015
Accepted (ET)
Dec 16, 2015 · 6:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469443
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 15, 2015 | M | 37,500 | $0.44 | A | 47,500 | D | |
| Common Stock | Dec 15, 2015 | S | 10,035 | $3.5663 | D | 37,465 | D | |
| Common Stock | Dec 16, 2015 | G | 27,465 | $0.00 | D | 10,000 | D | |
| Common Stock | Dec 16, 2015 | G | 27,465 | $0.00 | A | 39,965 | I | by Steven Franklin Brandwein Living Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $0.44 | Dec 15, 2015 | M | 37,500 | D | — | Dec 31, 2015 | Common Stock | 37,500 | 0 | D |
Explanation of responses
- F1The sale transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan (the "Plan"), adopted by the Reporting Person effective June 12, 2015.
- F2Represents transfer of shares to the Steven Franklin Brandwein Living Trust.
- F3The option is fully exercisable as of the date hereof.